Literature DB >> 16477186

Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patients.

Benjamin F Rodriguez1, Risa B Weisberg, Maria E Pagano, Steven E Bruce, Michael A Spencer, Larry Culpepper, Martin B Keller.   

Abstract

The current study examined the naturalistic course of generalized anxiety disorder (GAD) in a sample of 113 primary care patients across a 2-year period. Initial diagnoses were established using structured clinical interviews according to DSM-IV diagnostic criteria. Results indicated that the majority of patients meeting DSM-IV diagnostic criteria for GAD were still symptomatic to some degree after 2 years of follow-up. Rates of full and partial recovery from GAD, however, were found to be higher than those reported for previous studies of GAD in psychiatric patients. Diagnostic comorbidity, severity of psychosocial impairment, and gender were found to be significantly associated with achieving full or partial recovery from GAD. Psychiatric treatment was not found to be associated with time to full or partial recovery from GAD symptoms, likely due to a treatment-biasing effect. These results underscore that GAD is a chronic and persistent illness in primary care patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477186      PMCID: PMC3289410          DOI: 10.1097/01.nmd.0000198140.02154.32

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  28 in total

1.  Long-term follow-up of generalized anxiety disorder.

Authors:  D M Mancuso; M H Townsend; D E Mercante
Journal:  Compr Psychiatry       Date:  1993 Nov-Dec       Impact factor: 3.735

2.  Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs.

Authors:  W Katon; M Von Korff; E Lin; P Lipscomb; J Russo; E Wagner; E Polk
Journal:  Gen Hosp Psychiatry       Date:  1990-11       Impact factor: 3.238

3.  A brief assessment of psychosocial functioning of subjects with bipolar I disorder: the LIFE-RIFT. Longitudinal Interval Follow-up Evaluation-Range Impaired Functioning Tool.

Authors:  A C Leon; D A Solomon; T I Mueller; J Endicott; M Posternak; L L Judd; P J Schettler; H S Akiskal; M B Keller
Journal:  J Nerv Ment Dis       Date:  2000-12       Impact factor: 2.254

4.  Factors predicting the clinical course of generalised anxiety disorder.

Authors:  K A Yonkers; I R Dyck; M Warshaw; M B Keller
Journal:  Br J Psychiatry       Date:  2000-06       Impact factor: 9.319

5.  Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity?

Authors:  W Maier; M Gänsicke; H J Freyberger; M Linz; R Heun; Y Lecrubier
Journal:  Acta Psychiatr Scand       Date:  2000-01       Impact factor: 6.392

Review 6.  The treatment of generalized anxiety disorder in patients with depressive symptomatology.

Authors:  K Rickels; E Schweizer
Journal:  J Clin Psychiatry       Date:  1993-01       Impact factor: 4.384

7.  Nonpsychiatric illness among primary care patients with trauma histories and posttraumatic stress disorder.

Authors:  Risa B Weisberg; Steven E Bruce; Jason T Machan; Ronald C Kessler; Larry Culpepper; Martin B Keller
Journal:  Psychiatr Serv       Date:  2002-07       Impact factor: 3.084

8.  Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up.

Authors:  Kimberly A Yonkers; Steven E Bruce; Ingrid R Dyck; Martin B Keller
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

9.  Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders.

Authors:  Benjamin F Rodriguez; Risa B Weisberg; Maria E Pagano; Jason T Machan; Larry Culpepper; Martin B Keller
Journal:  Compr Psychiatry       Date:  2004 Mar-Apr       Impact factor: 3.735

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  20 in total

1.  Impairment and functioning in a sample of primary care patients with generalized anxiety disorder: results from the primary care anxiety project.

Authors:  Risa B Weisberg; Courtney Beard; Maria E Pagano; Kristin M Maki; Larry Culpepper; Martin B Keller
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Trajectories of change in anxiety severity and impairment during and after treatment with evidence-based treatment for multiple anxiety disorders in primary care.

Authors:  Jutta M Joesch; Daniela Golinelli; Cathy D Sherbourne; Greer Sullivan; Murray B Stein; Michelle G Craske; Peter P Roy-Byrne
Journal:  Depress Anxiety       Date:  2013-06-25       Impact factor: 6.505

3.  Longitudinal course of obsessive-compulsive disorder in patients with anxiety disorders: a 15-year prospective follow-up study.

Authors:  Brook A Marcks; Risa B Weisberg; Ingrid Dyck; Martin B Keller
Journal:  Compr Psychiatry       Date:  2011-02-23       Impact factor: 3.735

4.  Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial.

Authors:  Jerome H Taylor; Ewgeni Jakubovski; Michael H Bloch
Journal:  J Psychiatr Res       Date:  2015-04-04       Impact factor: 4.791

5.  Characteristics and predictors of social phobia course in a longitudinal study of primary-care patients.

Authors:  Courtney Beard; Ethan Moitra; Risa B Weisberg; Martin B Keller
Journal:  Depress Anxiety       Date:  2010-09       Impact factor: 6.505

6.  Predictors of remission from generalized anxiety disorder and major depressive disorder.

Authors:  Kristen M Kelly; Briana Mezuk
Journal:  J Affect Disord       Date:  2016-10-26       Impact factor: 4.839

7.  [Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings].

Authors:  Antoni Sicras-Mainar; Milagrosa Blanca-Tamayo; Ruth Navarro-Artieda; Javier Rejas-Gutiérrez
Journal:  Aten Primaria       Date:  2009-02-03       Impact factor: 1.137

Review 8.  Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review.

Authors:  Marina Dyskant Mochcovitch; Rafael Christophe da Rocha Freire; Rafael Ferreira Garcia; Antonio Egidio Nardi
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

9.  Two-year course of generalized anxiety disorder, social anxiety disorder, and panic disorder in a longitudinal sample of African American adults.

Authors:  Nicholas J Sibrava; Courtney Beard; Andri S Bjornsson; Ethan Moitra; Risa B Weisberg; Martin B Keller
Journal:  J Consult Clin Psychol       Date:  2013-09-16

Review 10.  Worry and generalized anxiety disorder: a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment.

Authors:  Michelle G Newman; Sandra J Llera; Thane M Erickson; Amy Przeworski; Louis G Castonguay
Journal:  Annu Rev Clin Psychol       Date:  2013       Impact factor: 18.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.